Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Adrenal Disorders
How will the newer JCEM guidelines on primary aldosteronism (PA) impact your management and screening of PA?
https://doi.org/10.1210/clinem/dgaf284
Related Questions
For patients with adrenal insufficiency who are on hydrocortisone replacement, would you recommend stress doses to cover for minor procedures such as dental work or thyroid fine-needle aspiration biopsies?
How do you manage patients who are positive for the 21-hydroxylase antibody but have no clinical or laboratory evidence of adrenal insufficiency?
Would you recommend testing for adrenal dysfunction in a euvolemic and hypertensive patient on anti-hypertensive therapy presenting with combined hyperkalemia and hyponatremia?
In patients with secondary adrenal insufficiency, when would you consider adding fludrocortisone to their steroid regimen?
How do you manage insomnia in a patient with Cushing syndrome, considering that elevated nighttime cortisol levels may contribute to their sleep disturbances?
In pregnant patients with Non Classical Congenital Adrenal hyperplasia, what factors help you determine the need for continued steroid use throughout pregnancy including labor and delivery?
How do you approach treatment of a patient with bilateral adrenal gland thickening & biochemical evidence of ACTH-independent hypercortisolism?
How often do you re-screen with autoantibody testing for type 1 diabetes if the initial test is negative in a patient with primary adrenal insufficiency?
Can 24-hour urine aldosterone levels be used to screen for primary aldosteronism in a patient taking finerenone?
Do you recommend combined baseline cortisol and DHEA-S testing to improve the efficiency and accuracy of adrenal insufficiency diagnosis?
